Alkermes (ALKS) Tops Q4 EPS by 39c, Offers Mixed FY Guidance
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $45.49 -1.32%
EPS Growth %: -108.2%
Financial Fact:
NET LOSS: -7.51M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -108.2%
Financial Fact:
NET LOSS: -7.51M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q4 EPS of $0.34, $0.39 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $315.8 million versus the consensus estimate of $255.09 million.
GUIDANCE:
Alkermes sees FY2019 EPS of $0.25-$0.43, versus the consensus of $0.56. Alkermes sees FY2019 revenue of $1.14-1.19 billion, versus the consensus of $1.1 billion.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- BMO Capital Starts Carter's (CRI) at Outperform
- Canaan Inc. (CAN) PT Lowered to $2 at BTIG
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
